Christine Emmanuel-Donnelly, BSc
Christine Emmanuel-Donnelly was appointed to the Board in September 2023. Christine is an experienced ASX listed company Director and Intellectual Property specialist. She is currently a Non-Executive Director for PolyNovo and Medical Developments International and non-ASX listed Pikcha Holdings Pty Ltd (trading as Seminal). Previous executive experience includes commercialisation and intellectual property roles at CSIRO,and RMIT. CSIRO is the premier Australian science agency covering all scientific disciplines, where she led and managed the Intellectual property portfolio and led the IP team, the commercialisation team and the equity portfolio team across all Business Units. Christine previously practised as a patent and trade marks attorney in leading AU and UK firms and Unilever (UK).